Matthew Angel - Insider Trading & Ownership

Location
10531 4 S Commons Drive, Suite 160 550, San Diego, CA
Summary
The estimated net worth of Matthew Angel is at least $8.65M dollars as of January 13, 2023. Matthew Angel is the President and CEO, Director of Eterna Therapeutics Inc. and owns shares of Ernexa Therapeutics Inc. (ERNA) stock worth about $8.65M.
Signature
/s/ Matthew Angel
All Insider Reports
All Insider Reports

Ownership of Matthew Angel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ERNA Ernexa Therapeutics Inc. President and CEO, Director $8.65M Jan 12, 2023

Insider Transactions Reported by Matthew Angel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.